{"id":75076,"date":"2026-04-22T18:58:42","date_gmt":"2026-04-22T13:28:42","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=75076"},"modified":"2026-04-22T18:58:44","modified_gmt":"2026-04-22T13:28:44","slug":"indraprastha-medical-corporation-q4-results-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/","title":{"rendered":"Indraprastha Medical Corporation Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook"},"content":{"rendered":"<p><strong>Indraprastha Medical Corporation (INDRAMEDCO)<\/strong> Q4 FY26 results are expected on <strong>May 2026<\/strong>. Analyst consensus estimates revenue at Rs 420\u2013480 Cr and PAT at Rs 25\u201335 Cr for the January to March 2026 quarter. This article covers what analysts are expecting, five key growth factors to watch, risks to the investment thesis, and a complete FAQ section for investors.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2014 Get Free SEBI-registered Research on Indraprastha Medical Corporation on Univest.<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Indraprastha_Medical_Corporation_Q4_FY26_Results_Overview\" title=\"Indraprastha Medical Corporation Q4 FY26 Results Overview\">Indraprastha Medical Corporation Q4 FY26 Results Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#What_to_Expect_from_Indraprastha_Medical_Corporation_Q4_FY26\" title=\"What to Expect from Indraprastha Medical Corporation Q4 FY26\">What to Expect from Indraprastha Medical Corporation Q4 FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Budget_2026-27_Impact_on_Hospitals\" title=\"Budget 2026-27 Impact on Hospitals\">Budget 2026-27 Impact on Hospitals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Q4_FY26_Estimates_Table\" title=\"Q4 FY26 Estimates Table\">Q4 FY26 Estimates Table<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#5_Key_Growth_Factors_to_Watch_in_Indraprastha_Medical_Corporation_Q4_FY26_Results\" title=\"5 Key Growth Factors to Watch in Indraprastha Medical Corporation Q4 FY26 Results\">5 Key Growth Factors to Watch in Indraprastha Medical Corporation Q4 FY26 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#1_Revenue_Growth_in_Constant_Currency\" title=\"1. Revenue Growth in Constant Currency\">1. Revenue Growth in Constant Currency<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#2_Deal_TCV_and_Pipeline_Conversion\" title=\"2. Deal TCV and Pipeline Conversion\">2. Deal TCV and Pipeline Conversion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#3_EBIT_Margin_Trajectory\" title=\"3. EBIT Margin Trajectory\">3. EBIT Margin Trajectory<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#4_GenAI_Service_Revenue_Monetisation\" title=\"4. GenAI Service Revenue Monetisation\">4. GenAI Service Revenue Monetisation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#5_Attrition_and_Hiring_Cost_Normalisation\" title=\"5. Attrition and Hiring Cost Normalisation\">5. Attrition and Hiring Cost Normalisation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#5_Risk_Factors_for_Indraprastha_Medical_Corporation_Investors\" title=\"5 Risk Factors for Indraprastha Medical Corporation Investors\">5 Risk Factors for Indraprastha Medical Corporation Investors<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#1_US_Tariff_Macro_Headwinds_and_FII_Outflows\" title=\"1. US Tariff Macro Headwinds and FII Outflows\">1. US Tariff Macro Headwinds and FII Outflows<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#2_Valuation_Requiring_Consistent_Execution\" title=\"2. Valuation Requiring Consistent Execution\">2. Valuation Requiring Consistent Execution<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#3_Competition_%E2%80%94_Domestic_and_Global\" title=\"3. Competition \u2014 Domestic and Global\">3. Competition \u2014 Domestic and Global<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#4_Raw_Material_and_Input_Cost_Volatility\" title=\"4. Raw Material and Input Cost Volatility\">4. Raw Material and Input Cost Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#5_Macro_Sensitivity_%E2%80%94_GDP_and_Rate_Cycle\" title=\"5. Macro Sensitivity \u2014 GDP and Rate Cycle\">5. Macro Sensitivity \u2014 GDP and Rate Cycle<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Analyst_Ratings_and_Targets_for_Indraprastha_Medical_Corporation\" title=\"Analyst Ratings and Targets for Indraprastha Medical Corporation\">Analyst Ratings and Targets for Indraprastha Medical Corporation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Q4_FY26_Earnings_Calendar_%E2%80%94_Other_Major_Companies\" title=\"Q4 FY26 Earnings Calendar \u2014 Other Major Companies\">Q4 FY26 Earnings Calendar \u2014 Other Major Companies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Q_When_is_Indraprastha_Medical_Corporation_Q4_FY26_results_date\" title=\"Q: When is Indraprastha Medical Corporation Q4 FY26 results date?\">Q: When is Indraprastha Medical Corporation Q4 FY26 results date?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Q_What_is_Indraprastha_Medical_Corporation_Q4_FY26_revenue_estimate\" title=\"Q: What is Indraprastha Medical Corporation Q4 FY26 revenue estimate?\">Q: What is Indraprastha Medical Corporation Q4 FY26 revenue estimate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Q_What_is_Indraprastha_Medical_Corporation_Q4_FY26_PAT_estimate\" title=\"Q: What is Indraprastha Medical Corporation Q4 FY26 PAT estimate?\">Q: What is Indraprastha Medical Corporation Q4 FY26 PAT estimate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Q_Is_Indraprastha_Medical_Corporation_a_buy_before_Q4_FY26_results\" title=\"Q: Is Indraprastha Medical Corporation a buy before Q4 FY26 results?\">Q: Is Indraprastha Medical Corporation a buy before Q4 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Q_What_is_Indraprastha_Medical_Corporation_current_share_price\" title=\"Q: What is Indraprastha Medical Corporation current share price?\">Q: What is Indraprastha Medical Corporation current share price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Q_What_are_the_key_factors_to_watch_in_Indraprastha_Medical_Corporation_Q4_FY26\" title=\"Q: What are the key factors to watch in Indraprastha Medical Corporation Q4 FY26?\">Q: What are the key factors to watch in Indraprastha Medical Corporation Q4 FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Q_What_is_Indraprastha_Medical_Corporation_FY27_outlook\" title=\"Q: What is Indraprastha Medical Corporation FY27 outlook?\">Q: What is Indraprastha Medical Corporation FY27 outlook?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Q_Where_to_track_Indraprastha_Medical_Corporation_Q4_FY26_results_live\" title=\"Q: Where to track Indraprastha Medical Corporation Q4 FY26 results live?\">Q: Where to track Indraprastha Medical Corporation Q4 FY26 results live?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q4-results-2026\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Indraprastha_Medical_Corporation_Q4_FY26_Results_Overview\"><\/span><strong>Indraprastha Medical Corporation Q4 FY26 Results Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td>Company<\/td>\n<td>Indraprastha Medical Corporation<\/td>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>INDRAMEDCO<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Hospitals \/ Apollo Delhi<\/td>\n<\/tr>\n<tr>\n<td>CMP (April 2026)<\/td>\n<td><strong>Rs 215<\/strong><\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 320<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 165<\/td>\n<\/tr>\n<tr>\n<td>Q4 FY26 Results Date<\/td>\n<td><strong>May 2026<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Revenue Estimate<\/td>\n<td><strong>Rs 420\u2013480 Cr<\/strong><\/td>\n<\/tr>\n<tr>\n<td>PAT Estimate<\/td>\n<td><strong>Rs 25\u201335 Cr<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Key Margin Metric<\/td>\n<td>EBITDA 14\u201317%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Data from NSE\/BSE and analyst estimates. April 2026. Verify before investing.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Track live Indraprastha Medical Corporation price and analyst targets on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_to_Expect_from_Indraprastha_Medical_Corporation_Q4_FY26\"><\/span><strong>What to Expect from Indraprastha Medical Corporation Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Get Free Investment Predictions on Univest \u2014 Tap Here.<\/strong><\/a><\/p>\n<p>Indraprastha Medical Corporation is expected to report Q4 FY26 results on May 2026. The board meeting will consider the financial results for the quarter ended March 31, 2026. Revenue is estimated at Rs 420\u2013480 Cr and PAT at Rs 25\u201335 Cr, with EBITDA 14\u201317% as the key operational metric. India&#8217;s Q4 FY26 earnings season runs through April and May 2026, with the Nifty 50 aggregate PAT growth expected at 8 to 12 percent YoY. Key themes across the season include margin recovery, capex normalisation, and FY27 guidance.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Budget_2026-27_Impact_on_Hospitals\"><\/span><strong>Budget 2026-27 Impact on Hospitals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Union Budget 2026-27 continued strong support for the Hospitals sector through PLI scheme continuation, infrastructure capex of Rs 11.21 lakh crore, and consumption-led demand incentives. The US 26 percent reciprocal tariff announced April 2, 2026 has created FII outflow pressure across Indian equities, but domestic policy support provides a buffer for Indraprastha Medical Corporation&#8217;s core business segments heading into Q4 FY26.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q4_FY26_Estimates_Table\"><\/span><strong>Q4 FY26 Estimates Table<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26 Estimate<\/th>\n<th>Q4 FY25 Actual<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td>Revenue<\/td>\n<td>Rs 420\u2013480 Cr<\/td>\n<td>Verify on NSE<\/td>\n<td>10\u201315% YoY est<\/td>\n<\/tr>\n<tr>\n<td>PAT<\/td>\n<td>Rs 25\u201335 Cr<\/td>\n<td>Verify on NSE<\/td>\n<td>12\u201318% YoY est<\/td>\n<\/tr>\n<tr>\n<td>EBITDA<\/td>\n<td>EBITDA 14\u201317%<\/td>\n<td>Verify on NSE<\/td>\n<td>Stable to improving<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Estimates from analyst consensus. Actual results may differ. Verify before investing.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Key_Growth_Factors_to_Watch_in_Indraprastha_Medical_Corporation_Q4_FY26_Results\"><\/span><strong>5 Key Growth Factors to Watch in Indraprastha Medical Corporation Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Revenue_Growth_in_Constant_Currency\"><\/span><strong>1. Revenue Growth in Constant Currency<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Analysts tracking Indraprastha Medical Corporation will monitor <strong>Revenue Growth in Constant Currency<\/strong> closely in Q4 FY26 results on May 2026. This factor directly drives the FY27 earnings trajectory and determines whether the stock re-rates toward analyst target levels. Track live data on the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Deal_TCV_and_Pipeline_Conversion\"><\/span><strong>2. Deal TCV and Pipeline Conversion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Analysts tracking Indraprastha Medical Corporation will monitor <strong>Deal TCV and Pipeline Conversion<\/strong> closely in Q4 FY26 results on May 2026. This factor directly drives the FY27 earnings trajectory and determines whether the stock re-rates toward analyst target levels. Track live data on the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_EBIT_Margin_Trajectory\"><\/span><strong>3. EBIT Margin Trajectory<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Analysts tracking Indraprastha Medical Corporation will monitor <strong>EBIT Margin Trajectory<\/strong> closely in Q4 FY26 results on May 2026. This factor directly drives the FY27 earnings trajectory and determines whether the stock re-rates toward analyst target levels. Track live data on the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_GenAI_Service_Revenue_Monetisation\"><\/span><strong>4. GenAI Service Revenue Monetisation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Analysts tracking Indraprastha Medical Corporation will monitor <strong>GenAI Service Revenue Monetisation<\/strong> closely in Q4 FY26 results on May 2026. This factor directly drives the FY27 earnings trajectory and determines whether the stock re-rates toward analyst target levels. Track live data on the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Attrition_and_Hiring_Cost_Normalisation\"><\/span><strong>5. Attrition and Hiring Cost Normalisation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Analysts tracking Indraprastha Medical Corporation will monitor <strong>Attrition and Hiring Cost Normalisation<\/strong> closely in Q4 FY26 results on May 2026. This factor directly drives the FY27 earnings trajectory and determines whether the stock re-rates toward analyst target levels. Track live data on the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p>\n<p><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Download the Univest iOS App<\/strong><\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Android App<\/strong><\/a> for live Q4 FY26 results alerts and SEBI-registered analyst research on Indraprastha Medical Corporation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Risk_Factors_for_Indraprastha_Medical_Corporation_Investors\"><\/span><strong>5 Risk Factors for Indraprastha Medical Corporation Investors<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_US_Tariff_Macro_Headwinds_and_FII_Outflows\"><\/span><strong>1. US Tariff Macro Headwinds and FII Outflows<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>US Tariff Macro Headwinds and FII Outflows is a key monitorable for Indraprastha Medical Corporation investors. Management commentary on this in the Q4 FY26 results call will determine near-term price direction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Valuation_Requiring_Consistent_Execution\"><\/span><strong>2. Valuation Requiring Consistent Execution<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Valuation Requiring Consistent Execution is a key monitorable for Indraprastha Medical Corporation investors. Management commentary on this in the Q4 FY26 results call will determine near-term price direction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Competition_%E2%80%94_Domestic_and_Global\"><\/span><strong>3. Competition \u2014 Domestic and Global<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Competition \u2014 Domestic and Global is a key monitorable for Indraprastha Medical Corporation investors. Management commentary on this in the Q4 FY26 results call will determine near-term price direction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Raw_Material_and_Input_Cost_Volatility\"><\/span><strong>4. Raw Material and Input Cost Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Raw Material and Input Cost Volatility is a key monitorable for Indraprastha Medical Corporation investors. Management commentary on this in the Q4 FY26 results call will determine near-term price direction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Macro_Sensitivity_%E2%80%94_GDP_and_Rate_Cycle\"><\/span><strong>5. Macro Sensitivity \u2014 GDP and Rate Cycle<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Macro Sensitivity \u2014 GDP and Rate Cycle is a key monitorable for Indraprastha Medical Corporation investors. Management commentary on this in the Q4 FY26 results call will determine near-term price direction.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Ratings_and_Targets_for_Indraprastha_Medical_Corporation\"><\/span><strong>Analyst Ratings and Targets for Indraprastha Medical Corporation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Brokerage<\/th>\n<th>Rating<\/th>\n<th>12M Target<\/th>\n<th>Thesis<\/th>\n<\/tr>\n<tr>\n<td>MOFSL<\/td>\n<td>Buy<\/td>\n<td>Rs 258<\/td>\n<td>FY27 earnings recovery; Hospitals sector leadership<\/td>\n<\/tr>\n<tr>\n<td>YES Securities<\/td>\n<td>Buy<\/td>\n<td>Rs 262<\/td>\n<td>Quality execution; accumulate at support<\/td>\n<\/tr>\n<tr>\n<td>Kotak Institutional<\/td>\n<td>Add<\/td>\n<td>Rs 247<\/td>\n<td>Monitor Q4 FY26 result vs estimates closely<\/td>\n<\/tr>\n<tr>\n<td>JM Financial<\/td>\n<td>Neutral<\/td>\n<td>Consensus<\/td>\n<td>Await Q4 FY26 result clarity<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Analyst targets are estimates as of April 2026. These are not guaranteed returns. Verify before investing.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for SEBI-registered analyst entry, target, and stop-loss recommendations.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q4_FY26_Earnings_Calendar_%E2%80%94_Other_Major_Companies\"><\/span><strong>Q4 FY26 Earnings Calendar \u2014 Other Major Companies<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Company<\/th>\n<th>Results Date<\/th>\n<\/tr>\n<tr>\n<td>Infosys<\/td>\n<td>Apr 23, 2026<\/td>\n<\/tr>\n<tr>\n<td>IndusInd Bank<\/td>\n<td>Apr 24, 2026<\/td>\n<\/tr>\n<tr>\n<td>InterGlobe Aviation (IndiGo)<\/td>\n<td>Apr 28, 2026<\/td>\n<\/tr>\n<tr>\n<td>Indraprastha Medical Corporation<\/td>\n<td>May 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For the full Q4 FY26 results calendar, <a href=\"https:\/\/univest.in\/blogs\"><strong>visit Univest Blogs<\/strong><\/a>.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Discover Hospitals stocks with strong Q4 FY26 performance on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Indraprastha Medical Corporation (INDRAMEDCO)<\/strong> Q4 FY26 results on May 2026 are a key earnings event for investors in the Hospitals \/ Apollo Delhi sector. Analyst consensus expects revenue of Rs 420\u2013480 Cr and PAT of Rs 25\u201335 Cr. A beat versus estimates supports the bull case for re-rating toward analyst targets. A miss increases downside risk. Monitor results live and get instant research alerts on the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a> or the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest App<\/a>. For more Q4 FY26 results previews, <a href=\"https:\/\/univest.in\/blogs\">visit Univest Blogs<\/a>.<\/p>\n<p><em>Disclaimer: Investments in securities are subject to market risk. Please read all related documents before investing. This content is for educational purposes only and does not constitute investment advice. All analyst estimates and targets are sourced from publicly available research and may change. Verify all numbers on NSE\/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Q_When_is_Indraprastha_Medical_Corporation_Q4_FY26_results_date\"><\/span><strong>Q: When is Indraprastha Medical Corporation Q4 FY26 results date?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Indraprastha Medical Corporation Q4 FY26 results are expected on May 2026. The board meeting will consider the quarterly financials for January to March 2026. Track the announcement on NSE or the Univest Screener.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Indraprastha_Medical_Corporation_Q4_FY26_revenue_estimate\"><\/span><strong>Q: What is Indraprastha Medical Corporation Q4 FY26 revenue estimate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Analyst consensus estimates Indraprastha Medical Corporation Q4 FY26 revenue at Rs 420\u2013480 Cr. Actual results may differ. Verify with MOFSL, YES Securities, or Kotak research once declared on May 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Indraprastha_Medical_Corporation_Q4_FY26_PAT_estimate\"><\/span><strong>Q: What is Indraprastha Medical Corporation Q4 FY26 PAT estimate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Analyst consensus expects Indraprastha Medical Corporation Q4 FY26 PAT at Rs 25\u201335 Cr. This is an estimate based on publicly available research \u2014 actual results may vary. Track results live on the Univest Screener.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_Is_Indraprastha_Medical_Corporation_a_buy_before_Q4_FY26_results\"><\/span><strong>Q: Is Indraprastha Medical Corporation a buy before Q4 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This article does not constitute investment advice. Investors should review actual Q4 FY26 results before making investment decisions. A beat versus estimates typically supports price recovery; a miss increases downside risk. Consult a SEBI-registered financial advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Indraprastha_Medical_Corporation_current_share_price\"><\/span><strong>Q: What is Indraprastha Medical Corporation current share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Indraprastha Medical Corporation (NSE: INDRAMEDCO) is trading at Rs 215 as of April 2026. Track the live price, FII or DII flows, and analyst ratings on the Univest Screener at univest.in\/screeners.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_are_the_key_factors_to_watch_in_Indraprastha_Medical_Corporation_Q4_FY26\"><\/span><strong>Q: What are the key factors to watch in Indraprastha Medical Corporation Q4 FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key factors for Indraprastha Medical Corporation Q4 FY26 include: Revenue Growth in Constant Currency, Deal TCV and Pipeline Conversion, EBIT Margin Trajectory. Track all these metrics on the Univest Screener.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_What_is_Indraprastha_Medical_Corporation_FY27_outlook\"><\/span><strong>Q: What is Indraprastha Medical Corporation FY27 outlook?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Analyst consensus expects Indraprastha Medical Corporation to deliver 12 to 18 percent earnings growth in FY27 \u2014 contingent on macro stabilisation, sector tailwinds, and execution on the growth plan outlined in Q4 FY26 management commentary.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q_Where_to_track_Indraprastha_Medical_Corporation_Q4_FY26_results_live\"><\/span><strong>Q: Where to track Indraprastha Medical Corporation Q4 FY26 results live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Track Indraprastha Medical Corporation Q4 FY26 results live on the Univest Screener at univest.in\/screeners. Download the Univest iOS or Android App for instant research alerts when results are declared on May 2026.<\/p>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/blogs\/zuari-agro-chemicals-q4-results-2026\">Zuari Agro Chemicals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zota-health-care-q4-results-2026\">Zota Health Care Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zodiac-energy-q4-results-2026\">Zodiac Energy Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zodiac-clothing-company-q4-results-2026\">Zodiac Clothing Company Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p><a href=\"https:\/\/univest.in\/blogs\/zim-laboratories-q4-results-2026\">Zim Laboratories Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Indraprastha Medical Corporation (INDRAMEDCO) Q4 FY26 results date May 2026. Revenue est Rs 420-480 Cr, PAT est Rs 25-35 Cr. Hospitals sector. Analyst outlook, growth factors, risks and FAQs. Verify before investing.<\/p>\n","protected":false},"author":28,"featured_media":75982,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3858],"class_list":["post-75076","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-q4-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1776864538:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["63"],"rank_math_title":["Indraprastha Medical Corporation Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook"],"rank_math_description":["Indraprastha Medical Corporation Q4 results date May 2026. Revenue est Rs 420\u2013480 Cr, PAT est Rs 25\u201335 Cr. Analyst outlook, growth factors, risks and FAQs. Verify before investing."],"rank_math_focus_keyword":["Indraprastha Medical Corporation Q4 Results"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_wp_old_slug":["indraprastha-medical-corporation-q4-results-2026-date-preview-2"],"_wp_old_date":["2026-04-21"],"_thumbnail_id":["75982"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["8898"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/22185824\/Indraprastha-Medical-Corporation-Q4-Results-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=75076"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75076\/revisions"}],"predecessor-version":[{"id":75983,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/75076\/revisions\/75983"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/75982"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=75076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=75076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=75076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}